PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 30 Sept, 14:18 UTC

A former congressman will take over for prominent lobbyist Steve Ubl. Elsewhere, recent buyout deals paid dividends for Mirum and AbbVie.